Transperineal laser ablation in the management of benign prostatic hyperplasia: an updated systematic review and pooled analysis (2025)

References

Sebastianelli A, Gacci M. Current status of the relationship between metabolic syndrome and lower urinary tract symptoms. Eur Urol Focus. 2018;4:25–7.
Article PubMed Google Scholar
Gacci M, Sebastianelli A, Salvi M, De Nunzio C, Vignozzi L, Corona G, et al. Benign prostatic enlargement can be influenced by metabolic profile: results of a multicenter prospective study. BMC Urol. 2017;17:22.
Article PubMed PubMed Central Google Scholar
Cornu JN, Gacci M, Hashim H, Herrmann TRW, Malde S, Netsch C, et al. EAU guidelines on non-neurogenic male lower urinary tract symptoms (LUTS). 2024;67:1099–109.
Gacci M, Sebastianelli A, Spatafora P, Corona G, Serni S, De Ridder D, et al. Best practice in the management of storage symptoms in male lower urinary tract symptoms: a review of the evidence base. Ther Adv Urol. 2018;10:79–92.
Article PubMed Google Scholar
Gandhi J, Weissbart SJ, Smith NL, Kaplan SA, Dagur G, Zumbo A, et al. The impact and management of sexual dysfunction secondary to pharmacological therapy of benign prostatic hyperplasia. Transl Androl Urol. 2017;6:295–304.
Article PubMed PubMed Central Google Scholar
La Vignera S, Aversa A, Cannarella R, Condorelli RA, Duca Y, Russo GI, et al. Pharmacological treatment of lower urinary tract symptoms in benign prostatic hyperplasia: consequences on sexual function and possible endocrine effects. Expert Opin Pharmacother. 2021;22:179–89.
Article PubMed Google Scholar
Gacci M, Ficarra V, Sebastianelli A, Corona G, Serni S, Shariat SF, et al. Impact of medical treatments for male lower urinary tract symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review and meta-analysis. J Sex Med. 2014;11:1554–66.
Article PubMed CAS Google Scholar
Ottaiano N, Shelton T, Sanekommu G, Benson CR. Surgical complications in the management of benign prostatic hyperplasia treatment. Curr Urol Rep. 2022;23:83–92.
Article PubMed Google Scholar
Porto JG, Arbelaez MCS, Blachman-Braun R, Bhatia A, Bhatia S, Satyanarayana R, et al. Complications associated with minimally invasive surgical therapies (MIST) for surgical management of benign prostatic hyperplasia: a Manufacturer and User Facility Device Experience (MAUDE) database review. World J Urol. 2023;41:1975–82.
Article PubMed Google Scholar
Cornu JN, Zantek P, Burtt G, Martin C, Martin A, Springate C, et al. Minimally invasive treatments for benign prostatic obstruction: a systematic review and network meta-analysis. Eur Urol. 2023;83:534–47.
Article PubMed Google Scholar
Gemma L, Pecoraro A, Sebastianelli A, Spatafora P, Sessa F, Nicoletti R, et al. Impact of minimally invasive surgical procedures for Male Lower Urinary Tract Symptoms due to benign prostatic hyperplasia on ejaculatory function: a systematic review. Prostate Cancer Prostatic Dis. 2024;27:404–21.
Article PubMed Google Scholar
Busetto GM, Lombardo R, De Nunzio C, Santoro G, Tocci E, Schiavone N, et al. Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH. Prostate Cancer Prostatic Dis. 2025;28:37–44.
Elterman DS, Zorn KC, Chughtai B, Bhojani N. Is it time to offer True Minimally Invasive Treatments (TMIST) for BPH? - A review of office-based therapies and introduction of a new technology category. Can J Urol. 2021;28:10580–3.
PubMed Google Scholar
Checcucci E, Veccia A, De Cillis S, Piramide F, Volpi G, Amparore D, et al. New ultra-minimally invasive surgical treatment for benign prostatic hyperplasia: a systematic review and analysis of comparative outcomes. Eur Urol Open Sci. 2021;33:28–41.
Article PubMed PubMed Central Google Scholar
Sessa F, Bisegna C, Polverino P, Gacci M, Siena G, Cocci A, et al. Transperineal laser ablation of the prostate (TPLA) for selected patients with lower urinary tract symptoms due to benign prostatic obstruction: a step-by-step guide. Urol Video J 2022;15:100167.
Article Google Scholar
Sessa F, Polverino P, Siena G, Bisegna C, Lo Re M, Spatafora P, et al. Transperineal laser ablation of the prostate (TPLA) for lower urinary tract symptoms due to benign prostatic obstruction. J Clin Med. 2023;12:793.
Article PubMed PubMed Central Google Scholar
Tzelves L, Nagasubramanian S, Pinitas A, Juliebø-Jones P, Madaan S, Sienna G, et al. Transperineal laser ablation as a new minimally invasive surgical therapy for benign prostatic hyperplasia: a systematic review of existing literature. Ther Adv Urol. 2023;15:17562872231198634.
Tafuri A, Panunzio A, De Carlo F, Luperto E, Di Cosmo F, Cavaliere A, et al. Transperineal laser ablation for benign prostatic enlargement: a systematic review and pooled analysis of pilot studies. J Clin Med. 2023;12:1860.
Article PubMed PubMed Central Google Scholar
Knoll T, Omar MI, Maclennan S, Hernández V, Canfield S, Yuan Y, et al. Key steps in conducting systematic reviews for underpinning clinical practice guidelines: methodology of the European Association of Urology. Eur Urol. 2018;73:290–300.
Article PubMed Google Scholar
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ 2021;372:n71.
Article PubMed PubMed Central Google Scholar
Sterne JAC, Savović J, Page MJ, Elbers RG, Blencowe NS, Boutron I, et al. RoB 2: a revised tool for assessing risk of bias in randomised trials. BMJ. 2019;366:l4898.
Sterne JA, Hernán MA, Reeves BC, Savović J, Berkman ND, Viswanathan M, et al. ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions. BMJ. 2016;355:i4919.
Cai HJ, Fang JH, Kong FL, Xu CK, Chen CH, Wang W, et al. Ultrasound-guided transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a new minimally invasive interventional therapy. Acta radiol. 2022;63:553–8.
Article PubMed Google Scholar
Patelli G, Ranieri A, Paganelli A, Mauri G, Pacella CM. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Cardiovasc Intervent Radiol. 2017;40:1440–6.
Article PubMed Google Scholar
Pacella CM, Patelli G, Iapicca G, Manenti G, Perretta T, Ryan CP, et al. Transperineal laser ablation for percutaneous treatment of benign prostatic hyperplasia: a feasibility study. Prostate Cancer Prostatic Dis. 2020;23:356–63.
Article PubMed CAS Google Scholar
de Rienzo G, Lorusso A, Minafra P, Zingarelli M, Papapicco G, Lucarelli G, et al. Transperineal interstitial laser ablation of the prostate, a novel option for minimally invasive treatment of benign prostatic obstruction. Eur Urol. 2021;80:95–103.
Article PubMed Google Scholar
Frego N, Saita A, Casale P, Diana P, Contieri R, Avolio PP, et al. Feasibility, safety, and efficacy of ultrasound-guided transperineal laser ablation for the treatment of benign prostatic hyperplasia: a single institutional experience. World J Urol. 2021;39:3867–73.
Article PubMed Google Scholar
Manenti G, Perretta T, Calcagni A, Ferrari D, Ryan CP, Fraioli F, et al. 3-T MRI and clinical validation of ultrasound-guided transperineal laser ablation of benign prostatic hyperplasia. Eur Radiol Exp. 2021;5:41.
Article PubMed PubMed Central Google Scholar
Polverino P, Lore M, Saladino M, Pecoraro A, Moscardi L, Rivetti A, et al. Could transperineal interstitial laser ablation of the prostate be the right option for highly comorbid patients with lower urinary tract symptoms due to benign prostatic obstruction? A preliminary single-center experience focusing on functional and safety outcomes. Minerva Urol Nephrol. 2023;76:646–9.
Bertolo R, Iacovelli V, Cipriani C, Carilli M, Vittori M, Antonucci M, et al. Ejaculatory function following transperineal laser ablation vs <scp>TURP < /scp> for benign prostatic obstruction: a randomized trial. BJU Int. 2023;132:100–8.
Article PubMed Google Scholar
Canat HL, Gurbuz C, Bozkurt M. Transurethral resection of the prostate (TURP) versus transperineal laser ablation (TPLA) due to benign prostatic hyperplasia (BPH): prospective and comparative study. Int Urol Nephrol. 2023;55:2747–52.
Article PubMed CAS Google Scholar
Destefanis P, Sibona M, Vitiello F, Vercelli E, Micai L, Montefusco G, et al. Trans - Perineal laser ablation of the prostate in high surgical risk patients affected by severe lower urinary tract symptoms related to benign prostatic obstruction. Prostate Cancer Prostatic Dis. 2023;27:693–9.
Laganà A, Di Lascio G, Di Blasi A, Licari LC, Tufano A, Flammia RS, et al. Ultrasound-guided SoracteLite^TM transperineal laser ablation (TPLA) of the prostate for the treatment of symptomatic benign prostatic hyperplasia (BPH): a prospective single-center experience. World J Urol. 2023;41:1157–62.
Article PubMed PubMed Central Google Scholar
Minafra P, Derienzo G, Gerbasi S, Cindolo L, Battaglia M, Ditonno P. Three years outcomes of transperineal laser ablation of the prostate. Minerva Urol Nephrol. 2023;75:471–8.
Patelli G, Altieri VM, Ierardi AM, Carnevale A, Chizzoli E, Baronchelli F, et al. Transperineal laser ablation of the prostate for symptomatic benign prostatic hyperplasia: long-term follow-up in 40 patients. J Vas Interv Radiol. 2024;35:1187–93.
Article Google Scholar
van Kollenburg R, van Riel L, Bloemen P, de Reijke T, Beerlage H, de Bruin D, et al. Transperineal laser ablation as treatment for benign prostatic obstruction: safety, feasibility and functional outcomes—A pilot study. BJUI Compass. 2024;5:52–9.
Article PubMed Google Scholar
Lo Re M, Polverino P, Rivetti A, Pecoraro A, Saladino M, Pezzoli M, et al. Transperineal laser ablation (TPLA) of the prostate for benign prostatic obstruction: the first 100 patients cohort of a prospective, single-center study. World J Urol. 2024;42:402.
Article PubMed PubMed Central Google Scholar
Bianco FJ, Luna E, Lopez-Prieto A, González P, Gheiler EL, Kaufman AM, et al. Office-based transperineal laser ablation for benign prostatic hyperplasia under local anesthesia: 2-year results from a dose range confirmatory trial. JU Open Plus. 2024;2:e00008.
Cai H, Zhu C, Fang J. Ultrasound-guided perineal laser ablation versus prostatic arterial embolization for benign prostatic hyperplasia: two similar short-term efficacies. Acta radiol. 2023;64:2033–9.
Article PubMed Google Scholar
Clavien PA, Barkun J, de Oliveira ML, Vauthey JN, Dindo D, Schulick RD, et al. The clavien-dindo classification of surgical complications. Ann Surg. 2009;250:187–96.
Article PubMed Google Scholar
Baerlocher MO, Nikolic B, Sze DY. Adverse event classification: clarification and validation of the society of interventional radiology specialty–specific system. J Vas Interv Radiol. 2023;34:1–3.
Article Google Scholar
Cocci A, Pezzoli M, Bianco F, Blefari F, Bove P, Cornud F, et al. Transperineal laser ablation of the prostate as a treatment for benign prostatic hyperplasia and prostate cancer: the results of a Delphi consensus project. Asian J Urol. 2024;11:271–9.
Article PubMed Google Scholar
Cornu JN, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C, et al. A systematic review and meta-analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol. 2015;67:1066–96.
Article PubMed Google Scholar
Lambertini L, Sandulli A, Coco S, Paganelli D, Cadenar A, Dell’Oglio P, et al. Complication rate across the minimally invasive surgical treatments (MISTs): where do we stand? A systematic review of the literature. Prostate Cancer Prostatic Dis. 2024 Oct 22. https://doi.org/10.1038/s41391-024-00900-5. Epub ahead of print. PMID: 39438691.

Download references